Constantine, G. D., Revicki, D. A., Kagan, R., Simon, J. A., Graham, S., Bernick, B., & Mirkin, S. (2019). Evaluation of clinical meaningfulness of estrogen plus progesterone oral capsule (TX-001HR) on moderate to severe vasomotor symptoms. Menopause.
Stile di citazione ChicagoConstantine, Ginger D., Dennis A. Revicki, Risa Kagan, James A. Simon, Shelli Graham, Brian Bernick, e Sebastian Mirkin. "Evaluation of Clinical Meaningfulness of Estrogen Plus Progesterone Oral Capsule (TX-001HR) On Moderate to Severe Vasomotor Symptoms." Menopause 2019.
Citazione MLAConstantine, Ginger D., et al. "Evaluation of Clinical Meaningfulness of Estrogen Plus Progesterone Oral Capsule (TX-001HR) On Moderate to Severe Vasomotor Symptoms." Menopause 2019.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.